IGC Pharma Partners with New to The Street for National Media Campaign

Got story updates? Submit your updates here. ›

IGC Pharma, a clinical-stage biotechnology company developing treatments for Alzheimer's disease, has announced a strategic 12-part national media partnership with New to The Street, a leading financial media platform. The collaboration is designed to enhance IGC Pharma's visibility across both institutional and retail investor audiences through a coordinated, multi-channel media strategy, including long-form televised interviews, national television commercial distribution, digital amplification, and high-visibility outdoor placements in key financial markets.

Why it matters

The partnership with New to The Street is expected to support broader market awareness for IGC Pharma as the company focuses on disciplined clinical execution and scientific development of its Alzheimer's disease treatments. Leveraging New to The Street's integrated platform, which combines national television exposure with digital, social, and outdoor media distribution, can help IGC Pharma reach a wider range of investors and raise the profile of its innovative therapies.

The details

As part of the initiative, IGC Pharma will be featured on New to The Street's sponsored programming on Fox Business and Bloomberg Television. The campaign will also be amplified through digital channels reaching a combined audience of more than 4.45 million YouTube subscribers, as well as through outdoor billboard placements in Times Square and the New York City Financial District, and earned media distribution across major U.S. broadcast affiliates.

• The partnership was announced on March 30, 2026.

What’s next

The 12-part national media campaign with New to The Street is expected to run throughout 2026, providing IGC Pharma with increased exposure and engagement with both institutional and retail investors.